SCHEMBL5075974

SCHEMBL5075974

CCOc1c(Cl)cc(OCc2ccccc2/C(=C\OC)C(=O)O)cc1Cl

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.46
ALDH1A1 P00352 2/20 0.46
HPGD P15428 2/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
ABL1 P00519 1/20 0.46
LMNA P02545 1/20 0.46
GAA P10253 1/20 0.46
MAPT P10636 1/20 0.46
RIN1 Q13671 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
TP53 P04637 1/20 0.40
HTT P42858 1/20 0.40
MRGPRX4 Q96LA9 2/20 0.40
KDM4E B2RXH2 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5075979 1.00 RAB9A (0.46) RAB9AALDH1A1HPGDMEN1KMT2A
SCHEMBL5076343 0.92 RAB9A (0.39) RAB9AALDH1A1HPGDMEN1KMT2A
SCHEMBL5080504 0.92 TP53 (0.39) RAB9AALDH1A1HPGDMEN1KMT2A
SCHEMBL5080510 0.92 TP53 (0.39) RAB9AALDH1A1HPGDMEN1KMT2A
SCHEMBL5079484 0.91 MRGPRX4 (0.44) RAB9AALDH1A1HPGDMEN1KMT2A
SCHEMBL5079482 0.91 MRGPRX4 (0.44) RAB9AALDH1A1HPGDMEN1KMT2A
SCHEMBL5080513 0.91 ALDH1A1 (0.38) RAB9AALDH1A1HPGDMEN1KMT2A
SCHEMBL5080526 0.91 ALDH1A1 (0.38) RAB9AALDH1A1HPGDMEN1KMT2A
SCHEMBL6151249 0.90 HIF1A (0.44) RAB9AALDH1A1HPGDMEN1KMT2A
SCHEMBL6151245 0.90 HIF1A (0.44) RAB9AALDH1A1HPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7435844-B2 Analogous compounds of strobilurines and their use as acaricides and insecticides ISAGRO RICERCA S.R.L. (IT) 2008-10-14 US disclosed
US-20060235075-A1 Analogous compounds of strobilurines and their use as acaricides and insecticides ISAGRO RICERCA S.R.L. (IT) 2006-10-19 US disclosed
EP-1494991-A1 ANALOGOUS COMPOUNDS OF STROBILURINES AND THEIR USE AS ACARICIDES AND INSECTICIDES Isagro Ricerca S.r.l. (IT) 2005-01-12 EP disclosed
WO-2003087032-A1 ANALOGOUS COMPOUNDS OF STROBILURINES AND THEIR USE AS ACARICIDES AND INSECTICIDES ISAGRO RICERCA S.R.L. (IT) 2003-10-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060235075-A1 Analogous compounds of strobilurines and their use as acaricides and insecticides DDT, RYR1, TPMT RAB9A 1215/4885ALDH1A1 13/4885HPGD 3764/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.